Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

HBI 2022: Dementia care clearly insufficient

The inexorable rise in the need for dementia care dominated the elderly care panel discussion at HBI 2022, whilst the global staffing crisis was also, inevitably, on the agenda. Is enough being done to prepare for the sharp rise in dementia patients expected in the coming years, and how are groups dealing with the war for talent? 

HBI 2022: M&A may slow in H2, but demand remains strong

“We are about to face a global recession,” conceded Hedley Goldberg, managing director at financial advisory group Rothschild, to a packed out audience at the plenary session on the M&A landscape at HBI 2022. “But it will be an unusual one with high levels of inflation and employment.”

HBI 2022: Trade associations preferred way for sector to defend itself

There were some eye catching audience poll results at the start of the Regulatory and Political Risk session at HBI 2022. A significant majority thought recent negative media coverage of for-profit health and care providers had impacted investor confidence - and that it would lead to new regulations.

Why Westminster NHS systems fail

Profound pessimism about NHS plans for integrated health and with NHS systems in the UK and Canada was on display from academics at the European Health Policymakers Group which celebrated its 21st year in an afternoon looking at what the group had learnt studying Beveridge (NHS) and Bismarckian (statutory insurer) models.

Twenty things we learned at HBI 2022

HBI 2022, the year's largest CxO-level for-profit healthcare services conference, took place in central London this week. The conference stages and the floor were awash with interesting ideas, staggering statistics, suggestions for building a better business and the buzz of new friendships being formed. As always, there were new things to learn. Here are twenty of our top take aways from this year's event.

HBI 2022: Lack of debt may hit M&A in second half

M&A deals in health care services such as the bid for British health and beauty retailer and pharmacy chain Boots are coming under threat as market uncertainty, interest rates and inflation soar. Massive deals may fail if debt dries up. This could lead to a further slow-down in M&A activity in the second half of 2022, following a record year 2021.

Find Us